It is indicated for the treatment of infection by Cryptosporidium parvum and Giardia lamblia in immunocompetent individuals and has been repurposed for the treatment of influenza.
This medication is suggested for the management of infections caused by Cryptosporidium parvum and Giardia lamblia in people with normal immune systems, and has been redirected for the treatment of influenza.